Oncotarget

Corrections:

Correction: Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells

PDF  |  How to cite

Oncotarget. 2025; 16:260-261. https://doi.org/10.18632/oncotarget.28713

Metrics: PDF 146 views  |   ?  

Mikaella Vouri1, Qian An1, Matthew Birt1, Geoffrey J. Pilkington1 and Sassan Hafizi1

1Institute of Biomedical and Biomolecular Science, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK

Published: April 04, 2025

Copyright: © 2025 Vouri et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: The authors discovered a duplication error in Figure 4C, where the pAkt blot for SNB-19 cells was mistakenly duplicated in place of the pAkt blot for UP007 cells.

The authors have provided uncropped Western blots for pAkt and Axl for both cell lines and replaced the incorrect image with the correct one from the original experiments. The band densitometry results, derived from the true original blots, remain unchanged and accurately displayed in the graphs.

This inadvertent error does not compromise the validity or integrity of the study’s findings, and this correction does not affect the conclusions of the study. The corrected Figure 4C, produced from the original data, is shown below.

Original article: Oncotarget. 2015; 6:16183-16197. DOI: https://doi.org/10.18632/oncotarget.3952.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28713